Antiphospholipid syndrome (APS) is an autoimmune thrombophilia characterized by
recurrent thrombotic events and/or pregnancy morbidity in the presence of antiphospholipid …

Antiphospholipid antibodies (aPL) cause vascular thrombosis (VT) and/or pregnancy
morbidity (PM). Differential mechanisms however, underlying the pathogenesis of these …

Antiphospholipid antibodies (aPL) not only are diagnostic biomarkers of antiphospholipid
syndrome (APS), but also exert a pathogenic role in mediating both thrombotic and obstetric …

Anti-phospholipid syndrome (APS) is defined by recurrent arterial/venous thrombosis and/or
fetal losses in the persistent presence of anti-phospholipid antibodies (aPL). In in vivo …

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by
arterial and venous thrombosis, and obstetric complications in the presence of …

Several, and not necessarily alternative, pathogenic mechanisms have been suggested to
sustain the thrombophilic diathesis of the anti-phospholipid syndrome. Among them …

Antiphospholipid antibodies (aPL) are both diagnostic and pathogenic antibodies. aPL
may:(1) interfere with anticoagulant mechanisms and fibrinolysis favoring a prothrombotic …

The antiphospholipid syndrome (APS) is defined by the occurrence of thrombotic events or
adverse pregnancy outcomes in individuals who persistently test positive for …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by pregnancy
morbidity or thrombosis and persistent antiphospholipid antibodies (aPL) that bind to the …

Antiphospholipid antibodies (aPL) are a heterogeneous group of autoantibodies, detected in
the sera of patients with both autoimmune and various non-autoimmune diseases. They are …